Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Drug Manufacturers - Major Cannabis Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and... see more

TSX:WEED - Post Discussion

Canopy Growth Corp > Couple of Cannabis misfits gain traction
View:
Post by lou64 on Dec 04, 2023 11:17am

Couple of Cannabis misfits gain traction

Without an ounce of positive news by way of Company OR Politically !! ( American Legalization )

People been banking on Substance Rescheduling but the Federal arm of Biden's good news for VOTES 
 

MISSES DEADLINE FOR DELIVERY .... last month missed and once again




The Department of Health and Human Services had a Saturday deadline to send Congress a report on marijuana’s “potential therapeutic effects” and recommendations to overcome “barriers” to researching it. HHS and other agencies were already late with a separate cannabis report that was due to lawmakers last month.

Comment by lou64 on Dec 04, 2023 11:36am
Oh wait .....My bad that needs a retraction !! Company news will surface but not by the company on the subject via news release or X ... It will come via third party source cause Canopy neglects or OPTS out of supplying. Nasdaq news will surface first half of the month and Canopy needs the much needed FLUFF news to combat reality
Comment by lou64 on Dec 04, 2023 11:53am
Reports ..... What reports ???????? ISNT CANOPY BANKING THE " FARM " TOTALLY ON AMERICAN LEGALIZATION THAT DOESNT PROVIDE REPORTS ? https://www.marijuanamoment.net/top-federal-health-agency-owes-congress-a-report-on-marijuanas-medical-uses-and-research-barriers-as-another-agency-misses-cannabis-deadline/
Canopy Growth Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities